Buscar
Mostrando ítems 1-10 de 377
Prophylaxis in Hemophilia
(HCPA/FAMED/UFRGS, 2023)
Molecular diagnosis of hemophilia A and B. Report of five families from Costa Rica
(Universidad de Costa Rica, 2004)
Hemophilia: a biography on therapeutical approaches
(HCPA/FAMED/UFRGS, 2023)
Prevention of bleeding in hemophilia patients with high-titer inhibitors
(Expert Reviews, 2015-06-01)
Inhibitor development is the most serious adverse event linked to the treatment of hemophilia, as it renders standard hemostatic therapy ineffective. Consequently, inhibitor patients are at increased risk for difficult-to-control ...
Phase 3 Clinical Trial: Perioperative Use of Nonacog Gamma, a Recombinant Factor IX, in Previously Treated Patients With Moderate/Severe Hemophilia B
(SAGE, 2020)
Hemostatic management is essential for ensuring the safety of patients with hemophilia during surgery. This phase 3, prospective, uncontrolled trial, evaluated hemostatic efficacy, consumption, and safety of a recombinant ...
Funcionamiento social en niños hemofílicos: Análisis de encuesta para determinar factores psicopatológicos de riesgo
(Sociedad Médica de Santiago, 2006)